Today, the district court for the Western District of Texas granted the government’s motion to dismiss the lawsuit brought by PhRMA and other organizations challenging the Drug Price Negotiation Program of the Inflation...more
2/13/2024
/ AstraZeneca ,
Boehringer ,
Bristol-Myers Squibb ,
Centers for Medicare & Medicaid Services (CMS) ,
Chamber of Commerce ,
Department of Health and Human Services (HHS) ,
Dismissals ,
Drug Pricing ,
Inflation Reduction Act (IRA) ,
Janssen Pharmaceuticals ,
Medicare ,
Medicare Act ,
Merck ,
Novartis ,
Novo Nordisk ,
Pharmaceutical Industry ,
PHRMA ,
Prescription Drugs ,
Secretary of HHS
On September 2, 2021, the parties in the Amgen v. Hospira (D. Del., No. 18-1064) Neupogen®/filgrastim litigation submitted a stipulation and proposed order to dismiss all claims and counterclaims in the litigation, with...more